152 related articles for article (PubMed ID: 2196280)
21. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms.
Zeki K; Spambalg D; Sharifi N; Gonsky R; Fagin JA
J Clin Endocrinol Metab; 1994 Nov; 79(5):1317-21. PubMed ID: 7962323
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Ras mutations in thyroid neoplasia.
Esapa CT; Johnson SJ; Kendall-Taylor P; Lennard TW; Harris PE
Clin Endocrinol (Oxf); 1999 Apr; 50(4):529-35. PubMed ID: 10468914
[TBL] [Abstract][Full Text] [Related]
24. N-ras mutation of thyroid tumor with special reference to the follicular type.
Oyama T; Suzuki T; Hara F; Iino Y; Ishida T; Sakamoto A; Nakajima T
Pathol Int; 1995 Jan; 45(1):45-50. PubMed ID: 7704243
[TBL] [Abstract][Full Text] [Related]
25. ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Katsuragi K; Kinoshita M; Saito S; Itakura M
Jpn J Cancer Res; 1992 Oct; 83(10):1057-62. PubMed ID: 1452458
[TBL] [Abstract][Full Text] [Related]
26. N-ras 61 oncogene mutations in Hürthle cell tumors.
Schark C; Fulton N; Jacoby RF; Westbrook CA; Straus FH; Kaplan EL
Surgery; 1990 Dec; 108(6):994-9; discussion 999-1000. PubMed ID: 2247846
[TBL] [Abstract][Full Text] [Related]
27. Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells.
Zhang PL; Calaf G; Russo J
Mol Carcinog; 1994 Jan; 9(1):46-56. PubMed ID: 8297485
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS.
Cyniak-Magierska A; Brzeziańska E; Januszkiewicz-Caulier J; Jarzab B; Lewiński A
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):594-9. PubMed ID: 17943694
[TBL] [Abstract][Full Text] [Related]
29. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
30. H-ras-1 point mutations in soft tissue sarcomas.
Wilke W; Maillet M; Robinson R
Mod Pathol; 1993 Mar; 6(2):129-32. PubMed ID: 8483882
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.
Soparker CN; O'Brien JM; Albert DM
Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2203-9. PubMed ID: 8505202
[TBL] [Abstract][Full Text] [Related]
32. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
33. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
[TBL] [Abstract][Full Text] [Related]
34. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
[TBL] [Abstract][Full Text] [Related]
35. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.
Moley JF; Brother MB; Wells SA; Spengler BA; Biedler JL; Brodeur GM
Cancer Res; 1991 Mar; 51(6):1596-9. PubMed ID: 1998949
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
37. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
38. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.
Shi YF; Zou MJ; Schmidt H; Juhasz F; Stensky V; Robb D; Farid NR
Cancer Res; 1991 May; 51(10):2690-3. PubMed ID: 2021946
[TBL] [Abstract][Full Text] [Related]
39. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
40. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.
Niepomniszcze H; Suárez H; Pitoia F; Pignatta A; Danilowicz K; Manavela M; Elsner B; Bruno OD
Thyroid; 2006 May; 16(5):497-503. PubMed ID: 16756473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
